Catabasis Pharmaceuticals to Present the MoveDMD Trial of Edasalonexent in Duchenne Muscular Dystrophy at the 24th International Congress of the World Muscle Society
Stock Information for null
Loading
Please wait while we load your information from QuoteMedia.